EAACI Congress 2023
BackFlash talks on asthma II
Sunday 11 Jun, 15:45 PM -
17:15 PM CEST
Hall Y 09+10
Flash Talks
15:45
ERS/ATS interpretative strategies for routine lung function tests: weak agreement between the 2005 and 2021 criteria for bronchodilator response
15:52
Molecular sensitisation profile to dogs in residents of Latvia and its connection with asthma and the course of allergic rhinitis
15:59
Obese and Non-obese Patients With Severe Asthma: Comparison of Omalizumab-Mepolizumab Treatment Outcomes
16:06
Is Airway Variability Increased in Patients with a History of NSAID Hypersensitivity?
16:13
Understanding the effect of clinical baseline characteristics on SABA reliever use in patients with moderate-severe asthma
16:20
The non-interventional real-life study with a combination of beclomethasone dipropionate and formoterol in HFA or DPI 100/6µg inhalers as maintenance and reliever therapy in patients with moderate persistent uncontrolled asthma
16:27
Burden of illness in a cohort of Italian patients eligible for biologics for asthma but not treated: a sub analysis of the real-world ISAR EVEREST study
16:34
Dysregulation of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) leads to lung fibrosis in house dust mite-induced experimental asthma
16:41
The influence of adipose tissue-derived mesenchymal stem cells (MSC) administration in the house dust mite (HDM)-induced mixed airway inflammation model
16:48
The influence of intranasal adipose tissue-derived mesenchymal stem cells (MSCs) administration on noninflamed lung in mice
16:55
Identification of two miRNA clusters in plasma-derived extracellular vesicles specifically linked to pathomechanims of obesity-associated low type-2 asthma
